See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
2
1
$0.00
$291.16K
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jul 24, 2026 Harmon Cyrus |
Harmon Cyrus
|
Sell |
12,500 | $11.71 | 12,500 $11.71 $146,425 |
Jul 23, 2026 Harmon Cyrus |
Harmon Cyrus
|
Sell |
12,500 | $11.58 | 12,500 $11.58 $144,738 |
Mar 04, 2026 Mitchell Shawnte |
Mitchell Shawnte
CLO
|
Sell |
24,767 | $24.25 | 24,767 $24.25 $600,600 |
Mar 04, 2026 Mitchell Shawnte |
Mitchell Shawnte
CLO
|
Sell |
233 | $24.69 | 233 $24.69 $5,753 |
Mar 03, 2026 Mitchell Shawnte |
Mitchell Shawnte
CLO
|
Sell |
15,000 | $23.01 | 15,000 $23.01 $345,150 |
Jan 20, 2026 Harmon Cyrus |
Harmon Cyrus
|
Sell |
10,000 | $26.88 | 10,000 $26.88 $268,800 |
Jan 15, 2026 Kovacs Shane William Charles |
Kovacs Shane William Charles
Ch. Operating & Financial Off.
|
Sell |
100,000 | $28.73 | 100,000 $28.73 $2,873,000 |
Jan 14, 2026 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
35,003 | $28.99 | 35,003 $28.99 $1,014,737 |
Jan 14, 2026 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
14,997 | $28.60 | 14,997 $28.60 $428,914 |
Jan 14, 2026 Harmon Cyrus |
Harmon Cyrus
|
Sell |
3,489 | $29.12 | 3,489 $29.12 $101,600 |
Jan 13, 2026 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
200 | $28.49 | 200 $28.49 $5,698 |
Jan 13, 2026 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
49,800 | $27.60 | 49,800 $27.60 $1,374,480 |
Jan 13, 2026 Kovacs Shane William Charles |
Kovacs Shane William Charles
Ch. Operating & Financial Off.
|
Sell |
3,822 | $28.01 | 3,822 $28.01 $107,054 |
Jan 12, 2026 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
10,000 | $28.34 | 10,000 $28.34 $283,400 |
Dec 23, 2025 Zojwalla Naseem |
Zojwalla Naseem
CMO
|
Sell |
99,509 | $27.66 | 99,509 $27.66 $2,752,419 |
Dec 22, 2025 Harmon Cyrus |
Harmon Cyrus
|
Sell |
2,881 | $28.53 | 2,881 $28.53 $82,195 |
Dec 22, 2025 Zojwalla Naseem |
Zojwalla Naseem
CMO
|
Sell |
100,000 | $28.04 | 100,000 $28.04 $2,804,000 |
Dec 19, 2025 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
1,225 | $28.08 | 1,225 $28.08 $34,398 |
Dec 19, 2025 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
43,729 | $30.40 | 43,729 $30.40 $1,329,362 |
Dec 19, 2025 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
6,046 | $31.39 | 6,046 $31.39 $189,784 |
Dec 19, 2025 CLARK IAN T |
CLARK IAN T
|
Sell |
41,840 | $30.48 | 41,840 $30.48 $1,275,283 |
Dec 19, 2025 CLARK IAN T |
CLARK IAN T
|
Sell |
193,056 | $29.71 | 193,056 $29.71 $5,735,694 |
Dec 19, 2025 Zojwalla Naseem |
Zojwalla Naseem
CMO
|
Sell |
57,079 | $28.03 | 57,079 $28.03 $1,599,924 |
Dec 19, 2025 Zojwalla Naseem |
Zojwalla Naseem
CMO
|
Sell |
12,921 | $28.93 | 12,921 $28.93 $373,805 |
Dec 19, 2025 CLARK IAN T |
CLARK IAN T
|
Sell |
29,904 | $28.83 | 29,904 $28.83 $862,132 |
Sep 18, 2025 Harmon Cyrus |
Harmon Cyrus
|
Sell |
3,086 | $8.32 | 3,086 $8.32 $25,676 |
Sep 18, 2025 Harmon Cyrus |
Harmon Cyrus
|
Sell |
10,000 | $8.33 | 10,000 $8.33 $83,300 |
Sep 16, 2025 Harmon Cyrus |
Harmon Cyrus
|
Sell |
1,914 | $8.08 | 1,914 $8.08 $15,465 |
Sep 16, 2025 Harmon Cyrus |
Harmon Cyrus
|
Sell |
10,000 | $8.04 | 10,000 $8.04 $80,400 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jan 08, 2025 Bain Capital Life Sciences Investors, LLC |
Bain Capital Life Sciences Investors, LLC
|
Buy |
300,000 | $5.76 | 300,000 $5.76 $1,727,370 |
Dec 17, 2024 Graham G. Walmsley |
Graham G. Walmsley
|
Buy |
700,761 | $6.75 | 700,761 $6.75 $4,730,137 |
Dec 17, 2024 Graham G. Walmsley |
Graham G. Walmsley
|
Sell |
700,761 | $6.75 | 700,761 $6.75 $4,730,137 |
Dec 11, 2024 Zojwalla Naseem |
Zojwalla Naseem
CMO
|
Sell |
320 | $9.39 | 320 $9.39 $3,005 |
Dec 11, 2024 Zojwalla Naseem |
Zojwalla Naseem
CMO
|
Sell |
14,202 | $8.66 | 14,202 $8.66 $122,989 |
Dec 11, 2024 Bohen Sean |
Bohen Sean
President and CEO
|
Sell |
55,907 | $8.66 | 55,907 $8.66 $484,155 |
Dec 11, 2024 Harmon Cyrus |
Harmon Cyrus
|
Sell |
7,958 | $8.66 | 7,958 $8.66 $68,916 |
Dec 11, 2024 Kovacs Shane William Charles |
Kovacs Shane William Charles
Ch. Operating & Financial Off.
|
Sell |
17,950 | $8.66 | 17,950 $8.66 $155,447 |
Dec 11, 2024 Kovacs Shane William Charles |
Kovacs Shane William Charles
Ch. Operating & Financial Off.
|
Sell |
406 | $9.39 | 406 $9.39 $3,812 |
Dec 11, 2024 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
13,314 | $8.66 | 13,314 $8.66 $115,299 |
Dec 11, 2024 Bohen Sean |
Bohen Sean
President and CEO
|
Sell |
1,267 | $9.39 | 1,267 $9.39 $11,897 |
Dec 11, 2024 Harmon Cyrus |
Harmon Cyrus
|
Sell |
179 | $9.39 | 179 $9.39 $1,681 |
Dec 11, 2024 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
300 | $9.39 | 300 $9.39 $2,817 |
Dec 10, 2024 Myles David C. |
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
|
Sell |
12,452 | $9.38 | 12,452 $9.38 $116,800 |
Dec 10, 2024 Bohen Sean |
Bohen Sean
President and CEO
|
Sell |
52,328 | $9.37 | 52,328 $9.37 $490,313 |
Dec 10, 2024 Kovacs Shane William Charles |
Kovacs Shane William Charles
Ch. Operating & Financial Off.
|
Sell |
16,803 | $9.37 | 16,803 $9.37 $157,444 |
Dec 10, 2024 Zojwalla Naseem |
Zojwalla Naseem
CMO
|
Sell |
13,283 | $9.37 | 13,283 $9.37 $124,462 |
Dec 10, 2024 Harmon Cyrus |
Harmon Cyrus
|
Sell |
8,256 | $9.37 | 8,256 $9.37 $77,359 |
Aug 01, 2024 Paradigm Biocapital Advisors LP |
Paradigm Biocapital Advisors LP
|
Sell |
1,870,499 | $14.92 | 1,870,499 $14.92 $27,898,493 |
Aug 01, 2024 Paradigm Biocapital Advisors LP |
Paradigm Biocapital Advisors LP
|
Sell |
529,501 | $14.92 | 529,501 $14.92 $7,897,507 |
TOP